Sun Pharma has offered to pay $14.00 a share in an all-cash deal, putting the Indian drugmaker on track to become one of the top three global players in women’s health.
About The Author
Sun Pharma has offered to pay $14.00 a share in an all-cash deal, putting the Indian drugmaker on track to become one of the top three global players in women’s health.
